KUALA LUMPUR - The World Health Organisation (WHO) prequalified a new dengue vaccine TAK-003 on May 10. TAK-003, developed by Takeda, is the second dengue vaccine to be prequalified by WHO. It is a ...
The World Health Organization has recommended the use of Tak-003 in settings with high dengue burden and transmission intensity. (Pixabay pic) KUALA LUMPUR: The World Health Organization (WHO) has ...
(MENAFN- Caribbean News Global) GENEVA, Switaerland – A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue ...
The prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible for procurement by UN agencies including UNICEF. Photo: AFP A new ...
The WHO has prequalified a second dengue vaccine called TAK-003 The TAK-003 vaccine has been made by the Japanese drug maker Takeda Pharmaceuticals TAK-003 can be administered to children aged 6 to 16 ...
The World Health Organisation (WHO) marked a significant milestone in the global fight against dengue fever with the prequalification of a new vaccine, TAK-003 on May 10, 2024. Developed by Takeda ...
The World Health Organization (WHO) has prequalified a new vaccine for dengue. TAK-003 Developed by Takeda is the second dengue vaccine to be prequalified by WHO. It is a live-attenuated vaccine ...
WHO said it had prequalified the second dengue vaccine, TAK-003 as a new weapon in the fight against malaria prevalent in tropical and subtropical regions. The World Health Organization said it had ...